LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Pulmonx Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$1.75−0.03 (-1.69%)
Close on Oct 19, 2026
- Market cap
- $74.32M
- P/E (TTM)
- –
- Dividend yield
- –
Pulmonx statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Pulmonx | Industry median |
|---|---|---|
| Market Cap | $75.16M | $229.23M |
| Enterprise Value | $56.85M | $194.73M |
| PS Ratio | 0.86 | 3.14 |
| PB Ratio | 1.92 | 3.19 |
| P/TBV Ratio | 2.04 | 4.69 |
Enterprise value
| Measure | Pulmonx | Industry median |
|---|---|---|
| EV / Sales | 0.65 | 2.93 |
Income (trailing twelve months)
| Measure | Pulmonx | Industry median |
|---|---|---|
| Revenue | $87.44M | $102.39M |
| Gross Profit | $67.38M | $60.36M |
| Operating Income | -$46.31M | -$4.31M |
| Pretax Income | -$47.52M | -$2.26M |
| Net Income | -$48.12M | -$6.57M |
| EBITDA | -$46.31M | -$1.98M |
| EPS (Diluted) | -$1.16 | -$0.07 |
Margins
| Measure | Pulmonx | Industry median |
|---|---|---|
| Gross Margin | 77.1% | 55.1% |
| Operating Margin | -53.0% | -6.04% |
| Pretax Margin | -54.3% | -4.11% |
| Profit Margin | -55.0% | -10.5% |
| EBITDA Margin | -53.0% | -2.67% |
| FCF Margin | -35.1% | -0.30% |
Returns
| Measure | Pulmonx | Industry median |
|---|---|---|
| Return on Equity (ROE) | -88.9% | -19.2% |
| Return on Assets (ROA) | -36.7% | -13.3% |
| Return on Invested Capital (ROIC) | -141.7% | -4.11% |
| Return on Capital Employed (ROCE) | -49.1% | -9.07% |
Growth
| Measure | Pulmonx | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -3.43% | 8.85% |
| Revenue Growth (3Y CAGR) | 19.0% | 7.08% |
| Revenue Growth (5Y CAGR) | 22.6% | 11.8% |
Balance sheet
| Measure | Pulmonx | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $55.84M | $37.33M |
| Total Debt | $37.53M | $72.66M |
| Net Cash (Debt) | $18.31M | $3.92M |
| Net Cash Per Share | $0.43 | $0.28 |
| Equity (Book Value) | $39.20M | $57.36M |
| Book Value Per Share | $0.91 | $2.81 |
| Tangible Book Value | $36.86M | $10.71M |
| Working Capital | $67.73M | $54.64M |
Financial position
| Measure | Pulmonx | Industry median |
|---|---|---|
| Current Ratio | 4.32 | 2.50 |
| Quick Ratio | 3.34 | 1.54 |
| Debt / Equity | 0.96 | 0.38 |
| Interest Coverage | -12.29 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Pulmonx | Industry median |
|---|---|---|
| Operating Cash Flow | -$30.56M | -$653.46K |
| Capital Expenditures | -$112.00K | -$3.69M |
| Free Cash Flow | -$30.67M | -$835.02K |
| FCF Per Share | -$0.71 | -$0.02 |
Efficiency
| Measure | Pulmonx | Industry median |
|---|---|---|
| Asset Turnover | 0.67 | 0.59 |
| Inventory Turnover | 1.23 | 2.21 |
| Revenue Per Employee | $295.41K | $322.75K |
| Profits Per Employee | -$162.55K | -$52.11K |
| Employee Count | 296 | 197 |
Dividends and yields
| Measure | Pulmonx | Industry median |
|---|---|---|
| Earnings Yield | -64.0% | -6.92% |
| FCF Yield | -40.8% | -0.62% |
Shares
| Measure | Pulmonx | Industry median |
|---|---|---|
| Shares Outstanding | 42,948,300 | 44,856,700 |
| Shares Change (YoY) | 4.69% | 3.35% |
| Shares Change (QoQ) | 1.68% | 0.27% |
| Float | 35,814,000 | 36,934,400 |
| Shares Held by Insiders | 16.6% | 10.6% |
| Shares Held by Institutions | 61.0% | 63.5% |
Taxes
| Measure | Pulmonx | Industry median |
|---|---|---|
| Income Tax | $596.00K | $1.52M |
Scores
| Measure | Pulmonx | Industry median |
|---|---|---|
| Altman Z-Score | -5.92 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Pulmonx's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.